NuVasive (NUVA) Misses Q4 EPS by 9c

NuVasive (NASDAQ: NUVA) reported Q4 EPS of $0.40, $0.09 worse than the analyst estimate of $0.49. Revenue for the quarter came in at $302.1 million versus the consensus estimate of $299.22 million.

GUIDANCE:

NuVasive sees FY2022 EPS of $2.05-$2.35, versus the consensus of $2.31.

For earnings history and earnings-related data on NuVasive (NUVA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c